These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 9814969

  • 1. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
    Marrero MB, Venema VJ, Ju H, Eaton DC, Venema RC.
    Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
    [Abstract] [Full Text] [Related]

  • 2. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
    Tang H, Zhao ZJ, Landon EJ, Inagami T.
    J Biol Chem; 2000 Mar 24; 275(12):8389-96. PubMed ID: 10722671
    [Abstract] [Full Text] [Related]

  • 3. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD, Sayyah J, VonDerLinden D, Johns M, Ostrov DA, Caldwell-Busby J, Sayeski PP.
    Cell Signal; 2007 Mar 24; 19(3):600-9. PubMed ID: 17027227
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
    Banes AK, Shaw S, Jenkins J, Redd H, Amiri F, Pollock DM, Marrero MB.
    Am J Physiol Renal Physiol; 2004 Apr 24; 286(4):F653-9. PubMed ID: 14678947
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose.
    Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB.
    Kidney Int; 2002 May 24; 61(5):1605-16. PubMed ID: 11967010
    [Abstract] [Full Text] [Related]

  • 6. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
    Wu DW, Stark KC, Dunnington D, Dillon SB, Yi T, Jones C, Pelus LM.
    Blood Cells Mol Dis; 2000 Feb 24; 26(1):15-24. PubMed ID: 10772872
    [Abstract] [Full Text] [Related]

  • 7. Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells.
    Doan T, Farmer P, Cooney T, Ali MS.
    Cell Signal; 2004 Mar 24; 16(3):301-11. PubMed ID: 14687660
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1.
    Shaw S, Bencherif M, Marrero MB.
    J Neurosci; 2003 Dec 03; 23(35):11224-8. PubMed ID: 14657181
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1.
    Venema RC, Venema VJ, Eaton DC, Marrero MB.
    J Biol Chem; 1998 Nov 13; 273(46):30795-800. PubMed ID: 9804857
    [Abstract] [Full Text] [Related]

  • 10. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1.
    Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T.
    Mol Cell Biol; 1996 Dec 13; 16(12):6985-92. PubMed ID: 8943354
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
    McWhinney CD, Dostal D, Baker K.
    J Mol Cell Cardiol; 1998 Apr 13; 30(4):751-61. PubMed ID: 9602424
    [Abstract] [Full Text] [Related]

  • 12. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia.
    Kim HY, Park EJ, Joe EH, Jou I.
    J Immunol; 2003 Dec 01; 171(11):6072-9. PubMed ID: 14634121
    [Abstract] [Full Text] [Related]

  • 13. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B.
    Mol Endocrinol; 1998 Apr 01; 12(4):556-67. PubMed ID: 9544991
    [Abstract] [Full Text] [Related]

  • 14. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor.
    Seta K, Sadoshima J.
    J Biol Chem; 2003 Mar 14; 278(11):9019-26. PubMed ID: 12522132
    [Abstract] [Full Text] [Related]

  • 15. Raft-mediated Src homology 2 domain-containing proteintyrosine phosphatase 2 (SHP-2) regulation in microglia.
    Kim HY, Park SJ, Joe EH, Jou I.
    J Biol Chem; 2006 Apr 28; 281(17):11872-8. PubMed ID: 16507579
    [Abstract] [Full Text] [Related]

  • 16. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.
    Ram PA, Waxman DJ.
    J Biol Chem; 1997 Jul 11; 272(28):17694-702. PubMed ID: 9211920
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase.
    Shibasaki Y, Matsubara H, Nozawa Y, Mori Y, Masaki H, Kosaki A, Tsutsumi Y, Uchiyama Y, Fujiyama S, Nose A, Iba O, Tateishi E, Hasegawa T, Horiuchi M, Nahmias C, Iwasaka T.
    Hypertension; 2001 Sep 11; 38(3):367-72. PubMed ID: 11566906
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C, Susini C, Melmed S.
    J Clin Invest; 1999 Nov 11; 104(9):1277-85. PubMed ID: 10545526
    [Abstract] [Full Text] [Related]

  • 19. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
    Li C, Friedman JM.
    Proc Natl Acad Sci U S A; 1999 Aug 17; 96(17):9677-82. PubMed ID: 10449753
    [Abstract] [Full Text] [Related]

  • 20. The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase.
    Marrero MB, Papke RL, Bhatti BS, Shaw S, Bencherif M.
    J Pharmacol Exp Ther; 2004 Apr 17; 309(1):16-27. PubMed ID: 14722323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.